Form4insider filings, from the source

Company · CIK 0001528115 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Annexon, Inc. · ANNX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $100k · 1sales $0 · 0net $100k
$10k$10k$100k$100k$1M$1MbuyssalesSep 2025Nov 2025Jan 2026Mar 2026May 2026Jul 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 24, 2026 PForm 4 →Sep 25, 4:15 pm EDTDouglas LovePRESIDENT AND CEO, Director26,065$3.83$99,829390,476+7.15%
Jun 11, 2026 MForm 4 →Jun 15, 4:15 pm EDTTed YednockEVP & CHIEF INNOVATION OFFICER30,646$1.85$56,698184,807—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 10, 2026 AForm 4 →Aug 12, 6:10 pm EDTMark S. BlumenkranzDirector175,000——175,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTWilliam D. WaddillDirector65,000——65,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTMuneer A SatterDirector65,000——65,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTWilliam A Jones Jr.Director65,000——65,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTBettina M. CockroftDirector65,000——65,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTJung ChoiDirector65,000——65,000—
Jun 11, 2026 AForm 4 →Jun 15, 4:15 pm EDTWilliam H. CarsonDirector65,000——65,000—
Jun 11, 2026 MForm 4 →Jun 15, 4:15 pm EDTTed YednockEVP & CHIEF INNOVATION OFFICER30,646——0—10b5-1